JNJ-41443532 - CAS 1228650-83-6
Catalog number: 1228650-83-6
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C22H25F3N4O3S
Molecular Weight:
482.52
COA:
Inquire
Targets:
CCR
Description:
This active molecular is a CCR2 receptor antagonist which is applicated for the treatment of type-2 diabetes mellitus under the development of Janssen Research & Development. In 2010, Phase-I clinical trials in Type-2 diabetes mellitus was on-going. in Belgium and USA.
Publictions citing BOC Sciences Products
  • >> More
Purity:
98%
Appearance:
Powder
Synonyms:
N-(2-((1-(trans-4-hydroxy-4-(5-thiazolyl)cyclohexyl)-3-azetidinyl)amino)-2-oxoethyl)-3-(trifluoromethyl)Benzamide
Solubility:
Soluble in DMSO
Storage:
-20°C Freezer
MSDS:
Inquire
Application:
type-2 diabetes mellitus
Quality Standard:
In-house standard
Shelf Life:
2 month in rt, long time
Quantity:
Milligrams-Grams
InChIKey:
CFKBNYUHQSQBSX-CYWCHRQTSA-N
InChI:
1S/C22H25F3N4O3S/c23-22(24,25)15-3-1-2-14(8-15)20(31)27-10-19(30)28-16-11-29(12-16)17-4-6-21(32,7-5-17)18-9-26-13-33-18/h1-3,8-9,13,16-17,32H,4-7,10-12H2,(H,27,31)(H,28,30)/t17-,21-
Canonical SMILES:
c1cc(cc(c1)C(=O)NCC(=O)NC2CN(C2)[C@H]3CC[C@@](CC3)(O)c4scnc4)C(F)(F)F
Current Developer:
Janssen Research & Development
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related CCR Products


CAS 879399-82-3 CCR3 antagonist 1

CCR3 antagonist 1
(CAS: 879399-82-3)

A potent antagonist of CCR3 (IC50= 1.8 nM)

Teijin compound 1
(CAS: 1313730-14-1)

Potent CCR2b antagonist

CAS 1262238-11-8 INCB3344

INCB3344
(CAS: 1262238-11-8)

A novel, potent and selective small molecule antagonist of the mouse CCR2 receptor

NSC5844
(CAS: 140926-75-6)

A CCR1 agonist; A bisquinoline compound

CAS 887401-92-5 INCB 3284

INCB 3284
(CAS: 887401-92-5)

Potent, selective and orally bioavailable CCR2 antagonist with IC50 of 3.7 nM

CAS 566203-88-1 AZD 2098

AZD 2098
(CAS: 566203-88-1)

AZD 2098 is a potent and selective CCR4 receptor antagonist (pIC50 = 7.8) used for the treatment of allergic rhinitis. CCR4 is a molecule that can drive the imm...

CAS 301648-08-8 UCB 35625

UCB 35625
(CAS: 301648-08-8)

Potent CCR1 and CCR3 antagonist

CAS 247580-43-4 SB 328437

SB 328437
(CAS: 247580-43-4)

Potent and selective CCR3 antagonist

CP-481715
(CAS: 212790-31-3)

CP-481715 is a potent and selective CCR1 antagonist with >100-fold selective for CCR1 as compared with a panel of G-protein-coupled receptors including related ...

CAS 1226894-87-6 YJC-10592

YJC-10592
(CAS: 1226894-87-6)

YJC-10592 is a CC chemokine receptor 2 (CCR2) antagonist (IC50 value 1.12 μM).

CAS 353791-85-2 J 113863

J 113863
(CAS: 353791-85-2)

Potent CCR1 antagonist

CAS 497223-25-3 Cenicriviroc

Cenicriviroc
(CAS: 497223-25-3)

Cenicriviroc is an inhibitor of CCR2 and CCR5 receptors, allowing it to function as an entry inhibitor which prevents the virus from entering into a human cell ...

CAS 445479-97-0 BMS CCR2 22

BMS CCR2 22
(CAS: 445479-97-0)

High affinity, potent CCR2 antagonist

CAS 217645-70-0 BX 471

BX 471
(CAS: 217645-70-0)

Selective CCR1 antagonist

CH0076989
(CAS: 54371-52-9)

CH0076989 is a small molecule agonist for CCR3. It activates a number of signalling pathways including chemotaxis and receptor internalisation.

AZD-5672
(CAS: 780750-65-4)

AZD5672 is CCR5 receptor antagonist originated by AstraZeneca. In Jul 2009, Phase-II for Rheumatoid arthritis in USA was discontinued.

CAS 624733-88-6 MK-0812

MK-0812
(CAS: 624733-88-6)

Potent and selective CCR2 antagonist with low nM affinity for CCR2 on human monocytes

CAS 1341224-83-6 PF-4136309

PF-4136309
(CAS: 1341224-83-6)

Potent, selective, and orally bioavailable CCR2 antagonist

CAS 376348-65-1 Maraviroc

Maraviroc
(CAS: 376348-65-1)

Selective CCR5 antagonist

CAS 887401-93-6 INCB 3284 dimesylate

INCB 3284 dimesylate
(CAS: 887401-93-6)

Potent, selective and orally bioavailable CCR2 antagonist with IC50 of 3.7 nM.

Quick Inquiry

Verification code

Featured Items